mortality/aging
• compared with Tg(lck-Notch3)#Issc mice
|
• 35% of mice die prior to 20 weeks of age
• of mice that survive beyond 20 weeks, 50% die over 30 weeks of age and 20% survive at 50 weeks of age
|
neoplasm
• 40% of mice that survive beyond 20 weeks of age exhibit lymphoproliferative disease (enlarged upper mediastium and 2- to 3-fold increase in spleen size and weight) compared with 95% of Tg(lck-Notch3)#Issc mice
|
immune system
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age
|
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age
|
growth/size/body
• 40% of mice that survive beyond 20 weeks of age exhibit enlarged upper mediastium compared with wild-type mice
|
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age
|
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age
|
hematopoietic system
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age
|
• 2- to 3-fold in 40% of mice that survive beyond 20 weeks of age
|